bioRxiv · 10.1101/2021.10.31.466544
Identifying metabolic adaptations during cardiotoxicity using paired transcriptomics andmetabolomics data integrated with a model of heart metabolism
Abstract
Improvements in the diagnosis and treatment of cancer has revealed the long-term side effects of chemotherapeutics, particularly cardiotoxicity. Here, we present paired transcriptomics and metabolomics data characterizing in vitro cardiotoxicity to three compounds: 5-fluorouracil, acetaminophen, and doxorubicin. Standard gene enrichment and metabolomics approaches identify some commonly affected pathways and metabolites but are not able to readily identify metabolic adaptations in response to cardiotoxicity. The paired data was integrated with a genome-scale metabolic network reconstruction (GENRE) of the heart to identify shifted metabolic functions, unique metabolic reactions, and changes in flux in metabolic reactions in response to these compounds. Using this approach, we confirm known mechanisms of doxorubicin-induced cardiotoxicity and provide hypotheses for metabolic adaptations in cardiotoxicity for 5-fluorouracil, doxorubicin, and acetaminophen.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Dougherty, B., Rawls, K. D., Jenior, M. L., Chun, B., Nagdas, S., Saucerman, J. J., Kolling, G. L., Wallqvist, A., Papin, J. A.. 2021-11-03. Identifying metabolic adaptations during cardiotoxicity using paired transcriptomics andmetabolomics data integrated with a model of heart metabolism. https://doi.org/10.1101/2021.10.31.466544
Cite the original work for its findings. Save a collection to share your selection of sources.